Skip to main content
Home Technologies Systems and methods for automatic radiation treatment plan generation and evidence-based customization for breast cancer
Systems and methods for automatic radiation treatment plan generation and evidence-based customization for breast cancer

Systems and methods for automatic radiation treatment plan generation and evidence-based customization for breast cancer

Unmet Need

Breast cancer is now the most commonly diagnosed form of the disease, with 2.3 million new cases in 2020. Some of the most effective therapies for cancer are based around beams of radiation applied by an external source, such as intensity-modulated radiation therapy (IMRT) and whole breast radiation therapy (WBRT). External radiation therapy is an almost $6B a year market, which is expected to grow at a CAGR of about 6.3% to almost $8B by 2023. However, these types of radiation treatments have to be planned for each individual patient so that the beams deliver the maximum dose to the target tumor while sparing nearby healthy tissue and organs at risk (OAR), a time-consuming process managed by a team of clinical professionals mostly relying on personal experience. The complexity and time commitment of manual breast treatment planning impedes the physician's ability to provide optimal care for their patients. There is a need for software that can quickly and automatically plan breast cancer radiation treatment plans that can be adjusted for each individual patient.

Technology

Duke inventors and colleagues have developed software systems and methods for automatic and customizable radiation treatment plan generation for breast cancer. The software takes in patient case and radiation therapy system data, performs an analysis using a knowledge model built using machine learning trained on data from similar breast cancer treatments, and presents a patient-specific radiation treatment plan. This plan and process can further be tweaked to account for physician and patient preference, but the software-generated plans are clinically comparable to human-produced plans. This technology has been successfully deployed at Duke Cancer Center clinics since May 2019 and has helped treat over 1,300 breast cancer patients.

Other Applications

This technology could also be applied to other cancer types and sites, as well as other instrumentation.

Advantages

  • Extensively validated in the clinic, with strong positive feedback from radiation planning teams
  • Faster plan design, on the order of several minutes compared to several hours, allowing for more approaches to be analyzed more efficiently
  • One-stop software includes fluence prediction, removing the need for manual planning dose calculation

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us